scispace - formally typeset
D

Daniel Böhmer

Researcher at Comenius University in Bratislava

Publications -  40
Citations -  366

Daniel Böhmer is an academic researcher from Comenius University in Bratislava. The author has contributed to research in topics: Population & Mesenchymal stem cell. The author has an hindex of 9, co-authored 39 publications receiving 311 citations.

Papers
More filters
Journal ArticleDOI

The tissue engineering of articular cartilage: cells, scaffolds and stimulating factors.

TL;DR: A brief review of the current status of cartilage tissue engineering and recent advances in the field is aimed at a brief review on the quality of life of affected individuals in all age groups.
Journal ArticleDOI

Comparison of in vitro chondrogenic potential of human mesenchymal stem cells derived from bone marrow and adipose tissue.

TL;DR: Results proved that both types of MSCs undergo the process of chondrogenic differentiation, and may play important role in the cartilage tissue engineering.
Journal ArticleDOI

The effect of simvastatin on lipid droplets accumulation in human embryonic kidney cells and pancreatic cancer cells.

TL;DR: Assessment of the impact of simvastatin on the amount of cytosolic lipid droplets (LDs) implicated in many biological processes including proliferation, inflammation, carcinogenesis, apoptosis, necrosis or growth arrest found it to contribute to the antiproliferative effects of statins.
Journal ArticleDOI

Morphology of in vitro expanded human muscle-derived stem cells.

TL;DR: Muscle-derived stem cells exhibited typical characteristics typical for mesenchymal stem cells and after analysis of their differentiation potential they could be used in tissue engineering and regenerative medicine.
Journal ArticleDOI

Effect of the Schiff base complex diaqua-(N-salicylidene-l-glutamato)copper(II) monohydrate on human tumor cells.

TL;DR: It is found that the copper(II) Schiff base complex is photochemically stable in aqueous systems and does not exhibit radical-scavenging activity when 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonate) cation radical was used as an oxidant, and could strongly participate in anticancer action via a free radical mechanism.